A Research Study for Patients With Prostate Cancer
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the activity of romidepsin (depsipeptide,FK228) in
patients with metastatic prostate cancer who have developed a rising prostate specific
antigen (PSA) while undergoing hormonal therapy.